FHMLS X, L.P. is 10% Owner at MBX Biosciences, Inc. (MBX). They have made 2 open-market trades across 2 companies since 2024, most recently 2025-09-26.
CIK 0001790880
2 open-market purchases totalling $12.1M since 2024, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.